Accel Clinical Research

Birmingham, Alabama 35216

0 studies enrolling now · 1 studies all time

What they study most

SARS-CoV-2

Studies at this site

• A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19) — Running, not enrolling